<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Constitutional deficit in the erythroid protein 4.1 (4.1R), a structural component of the erythrocyte membrane, is implicated in <z:hpo ids='HP_0004445'>hereditary elliptocytosis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Acquired deficit in protein 4.1R have been rarely described in <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Here, we report a series of six patients presenting a myelodysplastic or a <z:mpath ids='MPATH_512'>myeloproliferative disease</z:mpath> in association with an <z:hpo ids='HP_0004445'>elliptocytosis</z:hpo> curve on osmotic gradient ektacytometry and a significant decrease in protein 4.1R level </plain></SENT>
<SENT sid="3" pm="."><plain>We confirm that deficit in protein 4.1R is recurrent in <z:e sem="disease" ids="C0027022" disease_type="Neoplastic Process" abbrv="MPD">myeloid malignancies</z:e> and should be particularly investigated when deletion del (20 q) is present, since we found this chromosomal abnormality in four out of six patients </plain></SENT>
</text></document>